Stay updated with breaking news from Try Law. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from
/PRNewswire/ -- NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, has received a first safety report from a Southwestern...
/PRNewswire/ -- NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, has received a first safety report from a Southwestern...
A Trump-era program was intended to root out Chinese state-sponsored economic espionage. Instead, critics say, it stirred up a toxic mix of racial profiling and prosecutorial misconduct, leaving innocent scientists to suffer the consequences.
As Girardi Scandal Deepens, Lawmakers And Bar Trade Blame By Brandon Lowrey | July 21, 2021, 4:19 PM EDT State legislators are threatening the State Bar of California’s funding for next year, demanding answers as to why it failed for decades to stop famed lawyer Thomas V. Girardi as he allegedly stole from his clients. But the move has prompted the bar to place some of the blame on lawmakers’ unwillingness to increase its funding. This is the third story in our series examining Girardi and the system and culture that enabled him. Want to read this article? Try Law360 FRE...